Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Barata

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Drug Safety|June 3, 2021
Monitoring and Managing Lorlatinib Adverse Events in the Portuguese Clinical Setting: A Position PaperFernando Barata, Carlos Aguiar, Tiago Reis Marques, et al.
Revista Portuguesa De Pneumologia|February 23, 2007
[Pericardioperitoneal shunt in the treatment of pericardial effusions in neoplasic patients]Nuno Cortesão, Ana Figueiredo, Fernando Barata, et al.
Acta Medica Portuguesa|December 1, 2009
[Cost of cancer care in Portugal]António Araújo, Fernando Barata, Sérgio Barroso, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Evaluation of Current Antiemetic Therapy Response in Patients Undergoing MEC or HEC Regimens in PortugalAntónio Araújo, Nuno Tavares, Ana Luísa Faria, et al.
Cancer Investigation|March 7, 2009
Phase II study of celecoxib with cisplatin plus etoposide in extensive-stage small cell lung cancerAntónio M F Arúajo, Jose C Mendez, Ana L Coelho, et al.
Journal of the National Cancer Institute|August 22, 2002
Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapyJohan Vansteenkiste, Robert Pirker, Bartomeu Massuti, et al.
Cancer Treatment and Research Communications|June 15, 2023
Liquid biopsy in the management of advanced lung cancer: Implementation and practical aspectsGabriela Fernandes, Ana Rodrigues, Cláudia Matos, et al.
The Lancet. Oncology|September 19, 2014
Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient dataAntonio Rossi, Paolo Chiodini, Jong-Mu Sun, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 22, 2010
Phase II, double-blinded, randomized study of enzastaurin plus pemetrexed as second-line therapy in patients with advanced non-small cell lung cancerAlberto Chiappori, Gerold Bepler, Fabrice Barlesi, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Drug Safety|June 3, 2021
Monitoring and Managing Lorlatinib Adverse Events in the Portuguese Clinical Setting: A Position PaperFernando Barata, Carlos Aguiar, Tiago Reis Marques, et al.
Revista Portuguesa De Pneumologia|February 23, 2007
[Pericardioperitoneal shunt in the treatment of pericardial effusions in neoplasic patients]Nuno Cortesão, Ana Figueiredo, Fernando Barata, et al.
Acta Medica Portuguesa|December 1, 2009
[Cost of cancer care in Portugal]António Araújo, Fernando Barata, Sérgio Barroso, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Evaluation of Current Antiemetic Therapy Response in Patients Undergoing MEC or HEC Regimens in PortugalAntónio Araújo, Nuno Tavares, Ana Luísa Faria, et al.
Cancer Investigation|March 7, 2009
Phase II study of celecoxib with cisplatin plus etoposide in extensive-stage small cell lung cancerAntónio M F Arúajo, Jose C Mendez, Ana L Coelho, et al.
Journal of the National Cancer Institute|August 22, 2002
Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapyJohan Vansteenkiste, Robert Pirker, Bartomeu Massuti, et al.
Cancer Treatment and Research Communications|June 15, 2023
Liquid biopsy in the management of advanced lung cancer: Implementation and practical aspectsGabriela Fernandes, Ana Rodrigues, Cláudia Matos, et al.
The Lancet. Oncology|September 19, 2014
Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient dataAntonio Rossi, Paolo Chiodini, Jong-Mu Sun, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 22, 2010
Phase II, double-blinded, randomized study of enzastaurin plus pemetrexed as second-line therapy in patients with advanced non-small cell lung cancerAlberto Chiappori, Gerold Bepler, Fabrice Barlesi, et al.
Pageof 2